ChemicalBook > Product Catalog >API >Synthetic Anti-infective Drugs >Antifungal Drugs >Terbinafine

Terbinafine

Terbinafine Suppliers list
Company Name: Jinan Jianfeng Chemical Co., Ltd
Tel: +8615562555968
Email: info@pharmachemm.com
Products Intro: Product Name:Terbinafine hydrochloride
CAS:91161-71-6
Purity:99% Package:5KG;1KG;25kg Remarks:pharm intermediate
Company Name: Chengdu Aupone Pharmaceutical Co.Ltd.
Tel: +86-28-+86-28-87843998-6060-6060 +8618631098571
Email: lijiaqi@aupone.com
Products Intro: Product Name:Terbinafine
Purity:99.99 Package:10gram
Company Name: Shanghai Affida new material science and technology center
Tel: +undefined15081010295
Email: 2691956269@qq.com
Products Intro: Product Name:Terbinafine
CAS:91161-71-6
Purity:99 Package:1kg;|5kg;|25kg Remarks:5KG;1KG;25KG
Company Name: Henan Tianfu Chemical Co.,Ltd.
Tel: +86-0371-55170693 +86-19937530512
Email: info@tianfuchem.com
Products Intro: Product Name:Terbinafine
CAS:91161-71-6
Purity:99% Package:25KG;5KG;1KG
Company Name: Nanjing ChemLin Chemical Industry Co., Ltd.
Tel: 025-83697070
Email: product@chemlin.com.cn
Products Intro: CAS:91161-71-6
Purity:98% Package:g-Kg Remarks:White powder

Terbinafine manufacturers

  • Terbinafine
  • Terbinafine pictures
  • $0.00 / 10gram
  • 2024-03-18
  • CAS:
  • Min. Order: 10gram
  • Purity: 99.99
  • Supply Ability: 10Tons
  • Terbinafine
  • Terbinafine pictures
  • $0.00 / 1kg
  • 2024-03-15
  • CAS:91161-71-6
  • Min. Order: 1kg
  • Purity: 99
  • Supply Ability: 9000kg/per week
  • Terbinafine
  • Terbinafine  pictures
  • $9.00 / 1KG
  • 2023-05-17
  • CAS:91161-71-6
  • Min. Order: 1KG
  • Purity: 99.9
  • Supply Ability: 1 ton

Related articles

  • What is terbinafine used for?
  • Oral and topical treatment of dermatophytoses and onychomycoses. Terbinafine also shows activity in the topical treatment of p....
  • Mar 16,2024
Terbinafine Basic information
Product Name:Terbinafine
Synonyms:trans-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthylmethylamine;(e)-n-(6,6-dimethyl-2-hepten-4-ynyl)-n-methyl-1-naphthalenemethanamine;6-dimethyl-2-hepten-4-ynyl)-n-methyl-n-((e)-1-naphthalenemethanamin;sf-86-327;TERBINAFINE;1-Naphthalenemethanamine, N-(2E)-6,6-dimethyl-2-hepten-4-ynyl-N-methyl-;(E)-N-(6,6-I)imethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethanamine;rerbinafine
CAS:91161-71-6
MF:C21H25N
MW:291.43
EINECS:618-706-8
Product Categories:Inhibitors;Active Pharmaceutical Ingredients;Terbinafine;API
Mol File:91161-71-6.mol
Terbinafine Structure
Terbinafine Chemical Properties
Melting point 203-205 °C
Boiling point 417.9±33.0 °C(Predicted)
density 1.007±0.06 g/cm3(Predicted)
vapor pressure 0Pa at 25℃
storage temp. 2-8°C
solubility soluble in Methanol
form powder to crystal
pka6.92±0.50(Predicted)
color White to Light yellow
LogP3.3 at 37℃ and pH7
CAS DataBase Reference91161-71-6(CAS DataBase Reference)
Safety Information
Hazard Codes Xi
Risk Statements 36/37/38
Safety Statements 26-36
HS Code 2921450090
MSDS Information
Terbinafine Usage And Synthesis
OriginatorLamisil,Novartis,UK
UsesTerbinafine (Lamisil) is a second-generation allylamine that is related to naftifine; however, it is 10 to 100 times more potent in vitro. It is fungicidal, whereas griseofulvin, ketoconazole, itraconazole, and other azole derivatives are all fungistatic. Because it is fungicidal, duration of therapy is shorter, and relapse rates are less than with other oral or topical therapies. Terbinafine acts by inhibiting squalene epoxidase and thereby decreasing synthesis of ergosterol, an essential component of fungal cell membranes. It is highly lipophilic and concentrates in the stratum corneum, sebum, and hair follicles. Slightly better cure rates are attained with b.i.d. than with daily dosing.
Lamisil (Novartis) Tablets
DefinitionChEBI: A tertiary amine that is N-methyl-1-naphthalenemethylamine in which the amino hydrogen is replaced by a 3-(tertbutylethynyl)allyl group. An antifungal agent administered orally (generally as the hydrochloride salt) for the t eatment of skin and nail infections.
IndicationsTerbinafine (Lamisil) is a second-generation allylamine that is related to naftifine; however, it is 10 to 100 times more potent in vitro. It is fungicidal, whereas griseofulvin, ketoconazole, itraconazole, and other azole derivatives are all fungistatic. Because it is fungicidal, duration of therapy is shorter, and relapse rates are less than with other oral or topical therapies.
Terbinafine acts by inhibiting squalene epoxidase and thereby decreasing synthesis of ergosterol, an essential component of fungal cell membranes. It is highly lipophilic and concentrates in the stratum corneum, sebum, and hair follicles. Slightly better cure rates are attained with b.i.d. than with daily dosing.
Manufacturing ProcessTo an ice-cooled solution of N-methyl-1-naphthalenemethylamine hydrochloride (2.1 g) in methanol (40 ml) and water (10 ml) was added sodium hydroxide powder (2 g) followed by dropwise addition of epichlorohydrin (8 ml). The mixture was heated at 60°C for 3 h, then cooled to room temperature. Volatile materials were removed in vacuo and the residue was taken up in ethyl acetate and washed with water. The organic phase was collected, dried over sodium sulfate, filtered and evaporated to dryness. The crude mixture was purified by flash chromatrography on silica gel (grade 9385, Merck, 230-400 mesh, 60 A) using a solvent gradient of a mixture of hexane and ethyl acetate (95:5, 90:10 and 85:15) as eluent, affording the N-methyl-N-naphthylmethyl-2,3-epoxypropane (1.85 g, 81.5%) as an oil.
To a solution of 3,3-dimethylbutyne (2.95 ml) in dry THF (50 ml) at -78°C was added a 2.5 M solution of n-BuLi in hexane (10 ml) dropwise. The mixture was allowed to warm to room temperature over 15 min and stirred at that temparature for a further 15 min, then was cooled back to -78°C and BF3OEt2 (3 ml) was added dropwise. The mixture was stirred for 15 min and 1.8 g of N-methyl-N-naphthylmethyl-2,3-epoxypropane, dissolved in THF (10 ml), was added dropwise. After stirring at -78°C for 2 h, saturated sodium bicarbonate solution (15 ml) was added, and the reaction mixture was allowed to warm to room temperature. The mixture was extracted with ethyl acetate (2 times 25 ml), and the combined organic fractions was dried over sodium sulfate, filtered and concentrated in vacuo. The residue was purified by flash chromatrography on silica gel (grade 9385, Merck, 230-400 mesh, 60 a) using a mixture of hexane and ethyl acetate (85:15) as eluent, thereby affording the N-methyl-N-(1-naphthylmethyl)-2-hydroxy-heptan-4-ynyl-1-amine as an oil (1.95 g, 79%).
To an ice-cooled solution of N-methyl-N-(1-naphthylmethyl)-2-hydroxyheptan- 4-ynyl-1-amine (155 mg) in THF (10 ml) was added Et3N (0.35 ml) followed by methanesulfonyl chloride (0.075 ml). The resulting mixture was stirred at 0°C for 3 h, then filtered. The filtrate was concentrated in vacuo, dissolved in toluene (10 ml) and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) (0.37 ml) was added. The resulting mixture was heated at 80°C for 4 h, cooled to room temperature then poured onto a silica gel column and eluted with hexane (100%) followed by a mixture of hexane and ethyl acetate (95:5). Thus, a mixture of E- and Z-isomers of N-methyl-N-(1- naphthylmethyl)-6,6-dimethylhept-2-en-4-ynyl)-1-amine were obtained in a ratio of 2:5 (95 mg, 66%).
Therapeutic FunctionAntifungal
Synthesis Reference(s)Tetrahedron Letters, 29, p. 1509, 1988 DOI: 10.1016/S0040-4039(00)80338-X
Antimicrobial activityTerbinafine is active against a wide range of pathogenic fungi, including dermatophytes (Epidermophyton, Microsporum and Trichophyton spp.), various Candida spp., Aspergillus spp., some dimorphic fungi (Blastomyces dermatitidis, Histoplasma capsulatum and Sporothrix schenckii) and many dematiaceous fungi.
Acquired resistanceResistance has not been reported.
Pharmaceutical ApplicationsA synthetic allylamine available as the hydrochloride for oral and topical administration.
PharmacokineticsOral absorption: 70–80%
Cmax 250 mg oral: c. 1 mg/L after 2 h
Plasma half-life: c. 17 h
Volume of distribution: 1000 L
Plasma protein binding: >99%
Blood concentrations increase in proportion to dosage. It is lipophilic and is rapidly and extensively distributed to body tissues. It reaches the stratum corneum by diffusion through the dermis and epidermis, and secretion in sebum. Diffusion from the nail bed is the major factor in its rapid penetration of nails. It is metabolized by the liver and the inactive metabolites are mostly excreted in the urine. The elimination half-life is prolonged in patients with hepatic or renal impairment.
Clinical UseTerbinafine hydrochloride can be used in Tinea pedis, tinea corporis, tinea cruris, tinea capitis, Onychomycosis caused by dermatophytes.
Side effectsThese include abdominal discomfort, loss of appetite, nausea, diarrhea, headache, impairment of taste, rash and urticaria. Serious skin reactions, including Stevens– Johnson syndrome, and rare hepatotoxic reactions, including jaundice, cholestasis and hepatitis, are occasionally encountered.
Drug interactionsPotentially hazardous interactions with other drugs
Antibacterials: concentration reduced by rifampicin.
MetabolismTerbinafine undergoes extensive first pass loss. It is hepatically metabolised to two major inactive metabolites, 80% of which are renally excreted.
Tag:Terbinafine(91161-71-6) Related Product Information
1-Chloro-6,6-dimethyl-2-heptene-4-yne Terbinafine Hydrochloride Trimethylamine Aniline Bis(2-ethylhexyl)amine Meglumine Trimethyl borate Trimethylamine hydrochloride Flunixin meglumine Methylamine hydrochloride 3,3-Dichloro-2-(chloromethyl)-1-propene 1-Butene,2-chloro-3,3-dimethyl- Dichloropropene Terbinafine Terbinafine EP Impurity C Methyl-2-naphthaleneMethylaMine Hydrochloride cis-Terbinafine Hydrochloride (E)-6,6-DiMethyl-2-hepten-4-ynal